GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Island Pharmaceuticals ILA.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.33

0.00%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Island Pharmaceuticals — daily ASX:ILA

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Island Pharmaceuticals on TradingView ↗
Market value
A$87.4m
Last close × shares
Volume
217.4k
Shares, 9 Nov 2026

About Island Pharmaceuticals

Its shares trade on ASX under the ticker ILA.AX. It has been listed since 13 April 2021. In the fiscal year to 30 June 2025, it reported revenue of A$58,800 and a net loss of A$3.9m. At that date it held total assets of A$7.5m and shareholders' equity of A$7.2m.

Island Pharmaceuticals Ltd. is a drug research and repurposing company, focused on developing preventative or therapeutic drugs for viral infections. The company is headquartered in Melbourne, Victoria. The company went IPO on 2021-04-13. The firm is engaged in drug research and repurposing. The company is focused on developing preventative or therapeutic drugs for viral infections. The firm's lead asset, ISLA-101 is developed by its subsidiary, Isla Pharmaceuticals. ISLA-101 is a drug with a safety profile, being repurposed for the prevention and treatment of dengue fever and other mosquito (or vector) borne diseases. The drug also has the potential to be used to prevent or treat a number of viruses including dengue, Zika and chikungunya, and other diseases rife in tropical climates. The firm is also considering alternative formulations, including a long-acting oral formulation and intravenous formulations for severe dengue infections. The firm's subsidiary is Isla Pharmaceuticals Inc.

Figures and description from our data supplier, not checked against the company's own report.

More about Island Pharmaceuticals →

Latest on Island Pharmaceuticals

Our reporting

We have not reported on Island Pharmaceuticals yet.

Next results

3 Mar 2027

Due on 3 Mar 2027. Analysts expect earnings of -0.02 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Island Pharmaceuticals's ticker?

Island Pharmaceuticals trades as ILA.AX on ASX, under ISIN AU0000138869.

What was Island Pharmaceuticals's last closing price?

0.33 on 9 Nov 2026. The figure is in AUD and is never converted.

When does Island Pharmaceuticals next report results?

Results are expected on 3 Mar 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.